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Abstract
Titrating analgesic and sedative drugs in pediatric intensive care remains a challenge for caregivers due to the lack of pharmacodynamic knowledge in
this population. The aim of the current study is to explore the concentration-effect relationship for morphine-associated oversedation after cardiac
surgery in children aged 3 months to 3 years.Data on morphine dosing,as well as morphine plasma concentrations,were available from a previous study
on the pharmacokinetics of morphine after cardiac surgery in children. Oversedation was defined as scores below 11 on the validated COMFORT–
behavioral scale. Population pharmacokinetic-pharmacodynamic modeling was performed in NONMEM 7.3. The probability of oversedation as a
function of morphine concentration was best described using a step function in which the EC50 was 46.3 ng/mL. At morphine concentrations below
the EC50, the probability of oversedation was 2.9% (0.4& to 18%), whereas above the EC50 percentages were 13% (1.9% to 52%) (median value [95%
prediction interval from interindividual variability]).Additionally, the risk of oversedation was found to be increased during the first hours after surgery
(P < .001) and was significantly lower during mechanical ventilation (P < .005).We conclude that morphine concentrations above approximately 45
ng/mL may increase the probability of oversedation in children after cardiac surgery. The clinician must evaluate, on a case-by-case basis, whether the
analgesic benefits arising from dosing regimen associated with such concentrations outweigh the risks.
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Titrating analgesic and sedative drugs in the pediatric
intensive care unit remains a challenge for caregivers.
Before successful titration is achieved, individual pa-
tients can suffer from insufficient analgesic efficacy due
to underdosing or adverse effects such as apnea and
hypotension due to overdosing. With better knowledge
of the pharmacokinetics and pharmacodynamics of
analgesic and sedative drugs in the individual pediatric
patient, starting doses may be optimized to reduce the
need for subsequent titration.1
For postoperative care after cardiac surgery, mor-
phine is the primary analgosedative drug worldwide.2
The pharmacokinetics of morphine has been studied
extensively, including studies in special populations.3,4
The pharmacodynamics of morphine has been less
extensively examined, which has resulted in a lack of
consensus on dosing recommendations for morphine
in children after cardiac surgery, with advised doses
varying from 10 to 60 μg/kg per hour for a continuous
infusion and from 50 to 500 μg/kg for a loading dose.2
The range of morphine concentrations reported to
provide adequate analgesia in children is also very
broad at 4 to 65 ng/mL.5 Even less is known about
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the relationship between morphine concentration and
the probability of adverse effects related to overdosing,
which may not be of relevance in the short term and
when patients are intubated but could ultimately result
in prolonged pediatric intensive care unit stay.2,6 Addi-
tionally, the use of opioids in neonates and infants has
been associated with long-term neurodevelopmental
effects.7,8
Following cardiac surgery and in response to
validated pain and sedation scores, additional
morphine doses may often be required.2,9 An important
question is whether a morphine concentration can be
identified above which the probability of side effects
(eg, oversedation) increases. To date, no studies have
been performed exploring the relationship between
morphine concentration and oversedation. Therefore,
the aim of the current study has been to examine
the concentration-effect relationship for morphine-
associated oversedation after cardiac surgery in
children aged 3 months to 3 years.
Methods
Patients and Data Description
This article describes the analysis of the data from an
observational prospective study at Our Lady’s Chil-
dren’s Hospital, Dublin, that was approved by the
local ethics committee.3 Written informed consent for
the study was obtained from the parents preopera-
tively. The study included children aged between 3
and 36 months, admitted to the intensive care unit
after cardiac surgery. The exclusion criteria included
preoperative treatment with morphine or midazolam,
medical history of cardiothoracic surgery through ster-
notomy, and preoperative mechanical ventilation. The
original study was published and described in detail
elsewhere3 and is briefly summarized below.
For this analysis of oversedation, we used
COMFORT-B (Comprehensive Observation and
Monitoring for Our Richland Tots–Behavioral) scores
collected from the patients from this clinical study,
defining oversedation as COMFORT-B score <11, as
proposed by Ista et al.10 The end of the data collection
period was marked by 1 of the following events: a
switch from intravenous to oral morphine, discharge to
the ward, a procedure requiring general anesthesia, and
reintubation for any reason other than oversedation.
The analysis considered a total of 565 COMFORT-
B observations in 35 individuals, with a median age
of 6 months (range 3-31 months) and a median body
weight of 6.1 kg (range 3.6-12.9 kg). Twenty individuals
(57%) were diagnosed with trisomy 21. Patients under-
went surgery for the following congenital heart effects:
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1 patient with atrial septal defect, 9 patients with ven-
tricular septal defect, 16 patients with atrioventricular
septal defect, and 9 patients with tetralogy of Fallot.
Additional information on the patient population and
the standardized anesthesia used during surgery can be
found in the publication of the original clinical study.3
Postoperative Analgosedation Protocol
Children received a standardized general anesthetic reg-
imen without premedication as previously described.3
After discontinuation of cardiopulmonary bypass, a
morphine loading dose of 100 μg/kg was administered,
and a morphine infusion was started at 40 μg/kg
per hour. COMFORT-B assessments were regularly
performed after surgery as part of the postoperative
analgosedation protocol. The COMFORT-B scale has
been validated for pain and distress assessment in chil-
dren below 3 years of age, including those with Down
syndrome.11-13 Additional morphine, as 20- to 40-μg/kg
bolus doses, was provided when the COMFORT-B
score was>16 and numerical rating scale was above>3,
indicating moderate to severe pain.9 A COMFORT-
B score >16 in combination with a numerical rating
scale <4 was seen as an indication for additional
sedation requirements. At this point midazolam was
started in addition tomorphine. As part of the standard
of care, all patients received 3 intravenous doses of
acetaminophen for the first 24 hours (7.5 mg/kg for
children <10 kg and 15 mg/kg for children >10 kg).
Pharmacodynamic Model Analysis
To describe the probability of oversedation as a
function of morphine plasma concentrations, pop-
ulation pharmacokinetic-pharmacodynamic modeling
was performed using NONMEM 7.3 (ICON plc,
Dublin, Ireland).13 In the model, morphine plasma
concentrations from the previously developed phar-
macokinetic models of morphine in this cohort were
used.3 For the patients who also received midazolam,
midazolam concentrations from a previously developed
pharmacokinetic model for midazolam in this cohort
were taken into account (Valkenburg et al, unpublished
data). Both direct and indirect pharmacodynamicmod-
els were tested to characterize the effect of morphine
and midazolam, using the following functions: linear,
maximum effect (Emax), sigmoid Emax, and a step func-
tion (created by fixing the value of the Hill parameter
in a sigmoid Emax formula at 100). The NONMEM
code of the final model is provided in the Supplemental
Material.
Model selection was based on the objective function
value (–2 log likelihood). The patient characteristics
of body weight, age, sex, trisomy 21 status, and
mechanical ventilation status were tested as covariates
to explain the interindividual variability in the risk
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of oversedation and were included in the model if
this resulted in a significantly (P < .01) better fit of
the observed data, using the objective function value
and assuming a chi-squared distribution. For model
diagnostics, the residuals over time, over morphine
concentration, and over midazolam concentration were
inspected for the presence of trends in the observed
proportion of oversedation and themodel’s predictions.
Details on how these residuals were calculated can be
found in the Supplemental Material.
Model Simulations
To visualize the relationship between morphine con-
centration and probability of oversedation, we simu-
lated this relationship for 1000 individuals using the
final model. Additionally, to visualize the morphine
concentrations over time that can be expected based
on the dosing regimen applied in this study, and to
judge the risk of overdosing with this treatment pro-
tocol, we simulated the morphine concentrations using
the morphine dosing regimen of the original clinical
study (100 μg/kg morphine loading dose followed by
a continuous morphine infusion at 40 μg/kg per hour
for 24 hours), for a population of 1000 children with
a body weight of 6.13 kg (median body weight in
the study). For this simulation we used the previously
published pharmacokinetic model, developed in this
patient cohort.3
Results
Clinical Data
The analysis considered a total of 565 COMFORT-B
observations, with a median number of COMFORT-
B observations per patient of 14 (range 6-39). Of the
COMFORT-B observations, 74 (13%) were below 11,
indicating oversedation. COMFORT-B observations
were collected during amedian postoperative follow-up
of 37 hours (range 12.4-114 hours) after the morphine
loading dose. A total of 81% of the COMFORT-B
observations were collected while patients were me-
chanical ventilated.
Postoperative Analgosedation
During the study patients received a median cumulative
morphine dose of 1090 μg/kg, with a range of 424
to 4740 μg/kg. Four patients received continuous mor-
phine at an infusion rate higher than the starting infu-
sion rate of 40 μg/kg per hour. The number of morphine
rescue boluses per patient ranged from 0 to 13 (median
4). Total morphine dose given as bolus was on average
223 μg/kg (including the 100-μg/kg loading dose) with
a range of 100 to 420 μg/kg. Morphine concentrations
during COMFORT-B observations ranged from 3.9
to 254 ng/mL (median 28.7 ng/mL). Midazolam was
administered to 26 of the patients (74%), with a median
Table 1. Parameter Estimates for the Final Population Pharmacody-
namic Model
Parameter [Units] Estimate (RSE %)
Baseline logit probability (Base)Baseline probability [%] –2.11 (12%)10.8
Mechanical ventilation effect (Effectvent) [-] –1.46 (27%)
Morphine effect
Morphine Emax 1.59 (27%)
Morphine EC50 [ng/mL] 46.3 (3%)
Morphine Hill coefficient (n) 100 FIXED
Effect of time after loading dose
Time effect at t = 0 min (Effectt0) [-] 8.9 (27%)
Slope exponential decay time effect (Slopetime) [min−1] –0.0082 (23%)
Interindividual variability
Baseline logit probability (ω2) 1.15 (62%)
RSE indicates relative standard error of estimate;ω2, variance of interindivid-
ual variability.
The function for the logit probability of oversedation is: Logit P = Base +
E f f ectvent + Emax ×Cmor nCmor n+ EC50n + E f f ectt0 × eSlopetime×time , in which effects of me-
chanical ventilation (Effectvent),morphine concentration (Cmor), and time after
loading dose (time) are included. Effectvent is 0 when patient is not on
mechanical ventilation. The probability of oversedation (P) is defined as:
P = 100% × eLogit PeLogit P+1 .
cumulative dose of 761 μg/kg in these patients. Midazo-
lam concentrations during COMFORT-B observations
ranged from 0 to 1024 ng/mL (median 18.5 ng/mL).
Pharmacodynamic Model Analysis
By use of pharmacokinetic-pharmacodynamic model-
ing, a correlation of increased probability of overseda-
tion with increased morphine concentrations (P < .01)
and of decreased probability of oversedation with me-
chanical ventilation (P< .005) was identified. The effect
of morphine was best described using a step function,
implying that the EC10, EC50, and EC90 have similar
values: morphine concentration had a very low effect
on oversedation at low to moderate concentrations
(<45 ng/mL) but quickly reached its Emax when concen-
trations exceeded the estimated EC50 of 46.3 ng/mL. In
the model, interindividual variability in the probability
of oversedation was identified, with a coefficient of
variation of 147%. Finally, an exponentially decreasing
function over timewith an estimated half-life of 85min-
utes (P < .001) was identified as a predictor of prob-
ability of oversedation that characterized the higher
observed proportion of oversedation in the first hours
after the end of surgery that could not be explained
by morphine or midazolam concentrations. During the
covariate analysis we found that the addition of sex,
age, body weight, midazolam concentration, or trisomy
21 status as predictors of interindividual variability in
the probability of oversedation did not significantly
improve the model (P > .01). Therefore, none of these
covariates was included in the final model. The final pa-
rameter estimates are shown in Table 1. This finalmodel
adequately described the observed data regarding
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Figure 1. Effects of time after loading dose (A) and morphine concentration (B) on the probability of oversedation after cardiac surgery in pediatric
patients. Shown are the median (solid line) and 95% prediction interval (dotted lines) of 1000 children. Simulations in panel A are generated at low
morphine concentrations (<45 ng/mL), whereas the simulations in panel B are generated at a time when the initial high probability of oversedation
after the loading dose (A) has returned to baseline (>5 hours after loading dose).
oversedation, as there were no systematic differences
between the model predictions and observations in the
diagnostic plots (Supplemental Figure S1).
Figure 1 shows the influence of time and mor-
phine concentration on the probability of oversedation
during mechanical ventilation, depicted as the 95%
prediction interval of a population of 1000 simulated
individuals. Figure 1A shows that in the first hours after
the morphine loading dose, there is a high probability
of oversedation, even at low morphine concentrations
(<45 ng/mL), which quickly decreases with time to-
ward a baseline probability of oversedation with a
median of 2.9% (95% prediction interval 0.4% to 18%).
Figure 1B shows the concentration-effect relationship
of morphine-associated oversedation. The figure shows
that below the EC50 of 46.3 ng/mL, the probability
of oversedation at baseline was 2.9% (0.4% to 18%)
(median value [95%prediction interval]), whereas above
the EC50 the probability of oversedation increases to
13% (1.9% to 52%). The concentration-effect relation-
ship of morphine-associated oversedation is not shown
for patients who are not on mechanical ventilation,
as all observations at high morphine concentrations
(>46.3 ng/mL) were made during mechanical ventila-
tion only.
In order to establishwhich proportion of the patients
would exceed the EC50 of 46.3 ng/mL morphine, at
which a steep increase in the probability of oversedation
was observed, Figure 2 shows morphine concentration-
time profiles for 1000 individuals receiving a loading
dose of 100 μg/kg followed by a 40 μg/kg per hour
infusion. The figure shows that except for the first
hour after the loading dose of 100 μg/kg, a morphine
concentration exceeding 46.3 ng/mL is generally not
Figure 2. Morphine concentrations over time for 1000 simulated
children of 6.13 kg after cardiac surgery receiving a 100-μg/kg morphine
loading dose followed by a 40 μg/kg per hour continuous intravenous
infusion. The simulation does not include the administration of any
additional rescue morphine bolus doses. The black solid and dotted
lines indicate the median and 95% prediction interval of the morphine
concentrations in the 1000 simulated children, respectively. The gray line
indicates the EC50 of the pharmacodynamic model (46.3 ng/mL), above
which the probability of oversedation strongly increases.
reached without additional bolus doses. These findings
are in agreement with the clinical study in which 3 or
more additional morphine bolus doses were given to
all 9 patients who had 1 or more COMFORT-B assess-
ments with morphine concentrations above 46.3 ng/mL
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beyond the first few hours after the loading dose.
With higher infusion rates of intravenous maintenance
morphine (ie, 50 μg/kg per hour), morphine concen-
trations above 46.3 ng/mL will occur more frequently,
even without administration of additional bolus doses
(Supplemental Figure S2).
Discussion
In this study we aimed to quantify the concentration-
effect relationship of morphine-associated
oversedation in a population of children between
3 and 36 months old after cardiac surgery using
pharmacokinetic-pharmacodynamic modeling. The
probability of oversedation was found to increase at
morphine concentrations higher than approximately
45 ng/mL (from 2.9% to 13% in a typical patient) and
during the first hours after cardiac surgery (Figure 1).
Our results show that when we used the morphine
dose that was used in the clinical study (100 μg/kg
morphine loading dose followed by 40 μg/kg per
hour continuous infusion), morphine concentrations
will generally be below the threshold of 46.3 ng/mL.
This suggests that morphine-associated oversedation is
particularly of concern when morphine is uptitrated
beyond this dosing regimen through the administration
of additional morphine boluses or increases of the
continuous infusion rate, or in dosing regimens with
a starting infusion rate of continuous morphine of
50 μg/kg per hour or higher.
The probability of oversedation was highly variable;
in the majority of mechanically ventilated patients,
morphine concentrations above 46 ng/mL would still
only result in a probability of oversedation of ≤20%,
which can be considered acceptable if these high con-
centration are required for adequate analgesia. How-
ever, some patientsmight have very high probabilities of
oversedation (>50%) at high morphine concentrations,
which would need to be considered in titrating mor-
phine in children after cardiac surgery. Unfortunately,
we did not identify any patient characteristics in this
study population that could serve as a priori predictors
of the probability of oversedation of an individual
patient. Future work should quantify the relationship
between the morphine concentration and its analgesic
effect so that, combined our current results, we might
establish the morphine concentration at which the
balance between benefits and risks (ie, oversedation) is
optimized.
We also identified a high probability of oversedation
in the first hours after the morphine loading dose that
was administered following the discontinuation of the
cardiopulmonary bypass. This increased probability of
oversedation could not be explained by the morphine
or midazolam concentrations in these patients at that
time andwas therefore accounted for in themodel using
an empirical exponentially declining function with a
half-life of 85 minutes. This phenomenon might be
explained by residual effects of the general anesthe-
sia during surgery (which consisted of remifentanil,
isoflurane, sevoflurane, and muscle relaxants3). Such a
postanesthesia washout has previously been described
in pharmacodynamic studies on sedation levels after
craniofacial surgery in children who did not receive
morphine loading doses or continuous maintenance
infusions.14,15
We also found that during mechanical ventilation
the probability of oversedation was lower than after
extubation. The direction of this association was un-
expected because a deeper level of sedation can be
acceptable or even desirable during mechanical venti-
lation to avoid autoextubation. The lower probability
of oversedation during mechanical ventilation might
be explained as the behavioral response to the pain
and discomfort of mechanical ventilation, which would
increase the COMFORT-B score, lowering the prob-
ability of observing COMFORT-B scores below 11.
Because of the lack of observations at high morphine
concentrations in extubated children, we cannot con-
clude what the effect of such morphine levels would
be on oversedation rates in the absence of the an-
tagonistic effect of mechanical ventilation (shown in
Figure 1B).
The current analysis has some limitations.
COMFORT-B scores below 11 are used clinically
as an indication of oversedation in children during
analgesic and sedative treatment but could in theory
also be observed during deep sleep.10 The study
included a relatively small number of children, which
likely contributed to the fact that the covariate analysis
did not identify patient characteristics that could
predict part of the large interindividual variability
in morphine-associated oversedation. Additionally,
midazolam was administered to a subpopulation of
the children in this study. However, no statistically
significant association between the midazolam
concentration and the probability of oversedation
could be identified. This might be explained by the
fact that in this study midazolam was not administered
to all patients but was given only in response to
undersedation.
Conclusions
We explored the concentration-effect relationship of
morphine-associated oversedation in young children
after cardiac surgery and found that the probability
of oversedation is increased at morphine plasma
concentrations above a threshold of approximately
45 ng/mL. Our analysis indicates that after the first
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hour, morphine concentrations above this threshold are
almost exclusively expected in children who receive res-
cue morphine in addition to the standard starting dose
regimen of 40 μg/kg per hour or in those exposed to
prolonged treatment of more than 12 hours at this dose.
Whether or not the analgesic benefits from dosing prac-
tices associated with higher morphine concentrations
outweigh the risk should be evaluated on an individual
basis.
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